With headquarters in Bray, Ireland, Trinity Biotech PLC is a company specializing in the development, manufacture, and marketing of clinical diagnostic test kits. Founded in 1992, the company lists on the NASDAQ with a current market capitalization of $73.49M. They market diagnostic systems, including reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market.
Trinity’s products find use in the healthcare industry to detect infectious diseases, autoimmune disorders, and sexually transmitted disease, as well as blood coagulation disorders. The company makes diagnostic test kits that find use in detecting diseases such as lupus, celiac, and rheumatoid arthritis, hormonal imbalances, syphilis, chlamydia, and herpes. They also detect intestinal infections, lung/bronchial infections, cardiovascular diseases, diabetes, liver, and intestine disorders
The company’s products are part of efforts by health professionals to measure the level of haemoglobin A1c and other chemistry parameters in serum, plasma, and whole blood. In addition, the company is a major provider of raw materials to the life sciences industry. Trinity Biotech sells their diagnostic test kits direct to markets in the United States, Germany, France, and the United Kingdom. They utilize international distributors and strategic partners in over 75 other countries globally. The company has over 700 employees around the world, and a family of more than 500 products.
In addition to Bray, Ireland, Trinity Biotech has U.S. manufacturing facilities in Carlsbad, Concord, Jamestown, and Kansas City. They also have facilities in Lemgo, Germany and Umea Sweden. On June 27, 2008, Brendan Farrell, CEO of Trinity Biotech PLC presided over the NASDAQ closing bell to celebrate the U.S. National HIV Testing Day.
On June 26, 2008, Trinity Biotech announced their appointment by Akers Biosciences, Inc., a designer and manufacturer of rapid diagnostic screening and testing products, as a distributor of their PIFA Heparin/Platelet Factor-4 Rapid Assay (HPF4) in U.S. and German markets. Heparin is the most widely used intravenous anticoagulant.
Trinity Biotech continues to diagnose the healthcare market place to provide healthcare providers the advanced tools they need. They strive to maintain a high standard of quality and excellence as they innovate. Their goals are to bring to market the most advanced diagnostic test kits that clinics and other healthcare enterprises require.
Let us hear your thoughts below:
